Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Key CML research from ASH 2010

Jan Geissler - Co-Founder, CML Advocates Network
Key CML research from ASH 2010 ( Jan Geissler - Co-Founder, CML Advocates Network )
18 Feb 2011

Advances in the treatment of CLL

Prof Kanti Rai - Long Island Jewish Medical Center, New York, USA
Advances in the treatment of CLL ( Prof Kanti Rai - Long Island Jewish Medical Center, New York, USA )
18 Feb 2011

The role of plasma cell biology in multiple myeloma

Dr William Matsui - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA
The role of plasma cell biology in multiple myeloma ( Dr William Matsui - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )
18 Feb 2011

Key multiple myeloma research from ASH 2010

Prof Pieter Sonneveld - Erasmus University Rotterdam, Netherlands
Key multiple myeloma research from ASH 2010 ( Prof Pieter Sonneveld - Erasmus University Rotterdam, Netherlands )
18 Feb 2011

CLL related research from ASH 2010

Dr Michael Keating- MD Anderson Cancer Center, Texas, USA
CLL related research from ASH 2010 ( Dr Michael Keating- MD Anderson Cancer Center, Texas, USA )
18 Feb 2011

The DASISION chronic myeloid leukaemia trial

Dr Neil Shah - University of California, San Francisco, USA
The DASISION chronic myeloid leukaemia trial ( Dr Neil Shah - University of California, San Francisco, USA )
18 Feb 2011

Key lymphoma research from ASH 2010

Prof Wyndham Wilson - National Cancer Institute, Maryland, USA
Key lymphoma research from ASH 2010 ( Prof Wyndham Wilson - National Cancer Institute, Maryland, USA )
18 Feb 2011

The importance of myelodysplastic syndrome diagnosis

Dr Reinhard Stauder - Innsbruck Medical University, Innsbruck, Austria
The importance of myelodysplastic syndrome diagnosis ( Dr Reinhard Stauder - Innsbruck Medical University, Innsbruck, Austria )
18 Feb 2011

Haematological cancers in the elderly

Dr Reinhard Stauder - Innsbruck Medical University, Innsbruck, Austria
Haematological cancers in the elderly ( Dr Reinhard Stauder - Innsbruck Medical University, Innsbruck, Austria )
18 Feb 2011

ENESTnd trial comparing nilotinib and imatinib as first line CML therapy

Prof Timothy Hughes - Institute of Medical and Veterinary Science, Adelaide, Australia
ENESTnd trial comparing nilotinib and imatinib as first line CML therapy ( Prof Timothy Hughes - Institute of Medical and Veterinary Science, Adelaide, Australia )
18 Feb 2011

Signalling pathways as a target for cancer therapies

Prof Mariann Bienz - MRC Laboratory of Molecular Biology, Cambridge, UK
Signalling pathways as a target for cancer therapies ( Prof Mariann Bienz - MRC Laboratory of Molecular Biology, Cambridge, UK )
14 Feb 2011

Inotuzumab ozogamicin therapy for indolent B-cell non-Hodgkin's lymphoma

Prof Andre Goy - Hackensack University Medical Center, New Jersey, USA
Inotuzumab ozogamicin therapy for indolent B-cell non-Hodgkin's lymphoma ( Prof Andre Goy - Hackensack University Medical Center, New Jersey, USA )
13 Feb 2011